Get 20% lifetime commission for referring investors to digrin.com
here.
Immuron Limited ( IMRN) - Key Metrics
IMRN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0.44 | -$0.24 | -$0.09 | -$0.09 |
| 2026Q2 | $0.60 | -$0.27 | -$0.35 | -$0.36 |
| 2025Q4 | $0.56 | -$0.47 | -$0.37 | -$0.37 |
| 2025Q3 | $0.28 | -$0.23 | -$0.18 | -$0.18 |
| 2025Q2 | $0.70 | -$0.44 | -$0.70 | -$0.70 |
IMRN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -1.57 |
| 2026Q2 | 0% | -1.07 |
| 2025Q4 | 0% | -1.40 |
| 2025Q3 | 0% | -3.10 |
| 2025Q2 | 0% | -1.86 |
IMRN
Price: $0.98
52 week price:
Earnings Per Share: -0.40 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 1327
Ebitda: -6.8 millionMarket Capitalization: 7.0 million